Alvogen, Inc Recall: Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose
Alvogen, Inc Recall: Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Alvogen, Inc; Product: Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc
| Recalling firm | Alvogen, Inc |
|---|---|
| Product | Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-463-69 |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20170616 |
| Recall number | D-0940-2017 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →